About Proteasome subunit beta type-10
Proteasome subunit beta type-10 (PSMB10) is a protein
from Homo sapiens identified by UniProt accession
P40306, 273 residues long.
MolForge cross-references it against 0 known binders and
295 disease associations.
Target properties
| Protein name | Proteasome subunit beta type-10 |
| UniProt accession | P40306 |
| Gene | PSMB10 |
| Organism | Homo sapiens |
| Length | 273 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (295)
Diseases linked to this target (Open Targets).
- proteasome-associated autoinflammatory syndrome 5 · score 0.63
- HIV infection · score 0.46
- breast adenocarcinoma · score 0.30
- glioblastoma multiforme · score 0.28
- head and neck squamous cell carcinoma · score 0.28
- body fat percentage · score 0.17
- mean corpuscular volume · score 0.10
- multiple myeloma · score 0.09
- neoplasm · score 0.09
- severe combined immunodeficiency due to CARD11 deficiency · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P40306-F1 | alphafold | PREDICTED | 90.94 | — |
Amino-acid sequence (273 residues)
MLKPALEPRG GFSFENCQRN ASLERVLPGL KVPHARKTGT TIAGLVFQDG VILGADTRAT NDSVVADKSC EKIHFIAPKI YCCGAGVAAD AEMTTRMVAS KMELHALSTG REPRVATVTR ILRQTLFRYQ GHVGASLIVG GVDLTGPQLY GVHPHGSYSR LPFTALGSGQ DAALAVLEDR FQPNMTLEAA QGLLVEAVTA GILGDLGSGG NVDACVITKT GAKLLRTLSS PTEPVKRSGR YHFVPGTTAV LTQTVKPLTL ELVEETVQAM EVE
Explore Proteasome subunit beta type-10 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets